152 related articles for article (PubMed ID: 10526065)
1. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Funabiki T; Jinno O; Sakurai Y; Hasegawa S; Imazu H; Ochiai M
J Hepatobiliary Pancreat Surg; 1999; 6(3):286-93. PubMed ID: 10526065
[TBL] [Abstract][Full Text] [Related]
2. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.
Masuhara S; Kasuya K; Aoki T; Yoshimatsu A; Tsuchida A; Koyanagi Y
J Hepatobiliary Pancreat Surg; 2000; 7(2):198-205. PubMed ID: 10982614
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of 8-hydroxy-2'-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction.
Otani K; Shimizu S; Chijiiwa K; Yamaguchi K; Noshiro H; Tanaka M
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1363-9. PubMed ID: 11692064
[TBL] [Abstract][Full Text] [Related]
7. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
[TBL] [Abstract][Full Text] [Related]
8. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
9. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
10. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
11. Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Yang Y; Nobukawa B; Suda K
Langenbecks Arch Surg; 2003 Apr; 388(2):122-31. PubMed ID: 12684801
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenesis in the biliary system associated with APDJ.
Chao TC; Wang CS; Jan YY; Chen HM; Chen MF
J Hepatobiliary Pancreat Surg; 1999; 6(3):218-22. PubMed ID: 10526055
[TBL] [Abstract][Full Text] [Related]
13. Allelotype analysis of gallbladder carcinoma associated with anomalous junction of pancreaticobiliary duct.
Nakayama K; Konno M; Kanzaki A; Morikawa T; Miyashita H; Fujioka T; Uchida T; Miyazaki K; Takao S; Aikou T; Fukumoto M; Takebayashi Y
Cancer Lett; 2001 May; 166(2):135-41. PubMed ID: 11311485
[TBL] [Abstract][Full Text] [Related]
14. Relationship between types of common channel and development of biliary tract cancer in pancreaticobiliary maljunction.
Hara H; Morita S; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(44):322-5. PubMed ID: 11995442
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
16. Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel.
Kamisawa T; Funata N; Hayashi Y; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Yamaguchi T
Gastrointest Endosc; 2004 Jul; 60(1):56-60. PubMed ID: 15229426
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticobiliary maljunction and congenital biliary dilatation.
Kamisawa T; Kaneko K; Itoi T; Ando H
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):610-618. PubMed ID: 28691687
[TBL] [Abstract][Full Text] [Related]
18. IL-33 overexpression in gallbladder cancers associated with pancreatobiliary maljunction.
Tomioka Y; Sung YN; Sawada R; Hong SM; Akita M; Itoh T; Ajiki T; Fukumoto T; Zen Y
Histopathology; 2019 Sep; 75(3):365-375. PubMed ID: 30882917
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review).
Tsuchida A; Itoi T; Aoki T; Koyanagi Y
Oncol Rep; 2003; 10(6):1693-9. PubMed ID: 14534681
[TBL] [Abstract][Full Text] [Related]
20. Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.
Aoki Y; Aida J; Kawano Y; Nakamura KI; Izumiyama-Shimomura N; Ishikawa N; Arai T; Nakamura Y; Taniai N; Uchida E; Takubo K; Ishiwata T
J Gastroenterol; 2018 Feb; 53(2):291-301. PubMed ID: 29143121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
